Truist Financial Corp Sells 13,334 Shares of The Cooper Companies, Inc. $COO

Truist Financial Corp cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 17.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 63,413 shares of the medical device company’s stock after selling 13,334 shares during the period. Truist Financial Corp’s holdings in Cooper Companies were worth $5,197,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Danske Bank A S lifted its stake in Cooper Companies by 5.2% during the fourth quarter. Danske Bank A S now owns 98,119 shares of the medical device company’s stock worth $8,042,000 after purchasing an additional 4,892 shares during the last quarter. Citizens Financial Group Inc. RI lifted its stake in Cooper Companies by 9.0% during the fourth quarter. Citizens Financial Group Inc. RI now owns 7,824 shares of the medical device company’s stock worth $641,000 after purchasing an additional 643 shares during the last quarter. Wealthfront Advisers LLC boosted its position in Cooper Companies by 11.8% in the fourth quarter. Wealthfront Advisers LLC now owns 11,318 shares of the medical device company’s stock valued at $928,000 after buying an additional 1,199 shares in the last quarter. Comerica Bank boosted its position in Cooper Companies by 16.3% in the fourth quarter. Comerica Bank now owns 70,860 shares of the medical device company’s stock valued at $5,808,000 after buying an additional 9,940 shares in the last quarter. Finally, Physician Wealth Advisors Inc. boosted its position in Cooper Companies by 4,276.9% in the fourth quarter. Physician Wealth Advisors Inc. now owns 569 shares of the medical device company’s stock valued at $47,000 after buying an additional 556 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. Citigroup cut their target price on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Friday, March 6th. Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a research report on Wednesday, March 4th. Needham & Company LLC raised their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Finally, Barclays raised their target price on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $90.79.

Cooper Companies Price Performance

COO stock opened at $60.00 on Monday. The company has a fifty day moving average price of $71.18 and a 200-day moving average price of $76.08. The company has a market capitalization of $11.71 billion, a P/E ratio of 29.70, a PEG ratio of 1.55 and a beta of 0.89. The Cooper Companies, Inc. has a 52-week low of $59.68 and a 52-week high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts expect that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.